Axo Longevity: Human Performance Longevity Platform

We are globally scaling one of the fastest growing consumer health business models LifeX has ever seen

Medicine 3.0 is ready to spread worldwide

US players have started showing that replacing old healthcare (Medicine 2.0) can scale quickly. M 2.0 is reactive and misses "Four Horsemen" of chronic disease (heart disease, cancer, brain, metabolic). Medicine 3.0 is a rocket ship. Some of the fastest scaling companies in the history of health tech are moving in the US with subscriptions that are proactive, personalized, and data-driven; integrating biomarkers, sports science, AI, nutrition, and mental health for disease prevention.

We are taking it global. We have assembled a team of veteran startup builders and scalers to capture this opportunity in the dozens of countries where this model is waiting to be deployed, first in 4 European countries.

Axo Longevity is building Europe's first high-performance consumer health platform for this new era.

Mission

Axo Longevity’s mission is to unlock top human performance and health span for everyone.

Why Now and Why Europe

Product & Philosophy

A €499/year membership includes: